Back
Chemomab Therapeutics Stock Price Chart
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Sell
26
CMMB
Chemomab Therapeutics
Last Price:
$1.22
Seasonality Move:
-7.83%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.-
The current trend is moderately bearish and CMMB is experiencing selling pressure, which indicates risk of future bearish movement.
Chemomab Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.28 | Sell |
| 20-day SMA: | 1.33 | Sell |
| 50-day SMA: | 1.25 | Sell |
| 200-day SMA: | 1.58 | Sell |
| 8-day EMA: | 1.26 | Sell |
| 20-day EMA: | 1.29 | Sell |
| 50-day EMA: | 1.16 | Buy |
| 200-day EMA: | 0.56 | Buy |
Chemomab Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 37.52 | Sell |
| Chaikin Money Flow: | -43355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.26 - 1.38) | Sell |
| Bollinger Bands (100): | (1.12 - 1.8) | Sell |
Chemomab Therapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Chemomab Therapeutics Stock
Is Chemomab Therapeutics Stock a Buy?
-
Chemomab Therapeutics share price is 1.20 while CMMB 8-day simple moving average is 1.28, which is a Sell signal.
-
The stock price of CMMB is 1.20 while Chemomab Therapeutics 20-day SMA is 1.33, which makes it a Sell.
-
Chemomab Therapeutics 50-day simple moving average is 1.25 while CMMB share price is 1.20, making it a Sell technically.
-
CMMB stock price is 1.20 and Chemomab Therapeutics 200-day simple moving average is 1.58, creating a Sell signal.
CMMB Technical Analysis vs Fundamental Analysis
Sell
26
Chemomab Therapeutics (CMMB)
is a Sell
Is Chemomab Therapeutics a Buy or a Sell?
-
Chemomab Therapeutics stock is rated a SellThe current Chemomab Therapeutics [CMMB] share price is $1.20. The Score for CMMB is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Chemomab Therapeutics Stock Info
Market Cap:
22.6M
Price in USD:
1.20
Share Volume:
72.3K
Chemomab Therapeutics 52-Week Range
52-Week High:
2.55
52-Week Low:
0.78
Sell
26
Chemomab Therapeutics (CMMB)
is a Sell
Chemomab Therapeutics Share Price Forecast
-
What is the Chemomab Therapeutics stock price today?The Chemomab Therapeutics stock price is 1.20 USD today.
-
Will CMMB stock go up or go down?Chemomab Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Chemomab Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Chemomab Therapeutics is overvalued.
Is Chemomab Therapeutics Stock a Buy?
-
Chemomab Therapeutics share price is 1.20 while CMMB 8-day exponential moving average is 1.26, which is a Sell signal.
-
The stock price of CMMB is 1.20 while Chemomab Therapeutics 20-day EMA is 1.29, which makes it a Sell.
-
Chemomab Therapeutics 50-day exponential moving average is 1.16 while CMMB share price is 1.20, making it a Buy technically.
-
CMMB stock price is 1.20 and Chemomab Therapeutics 200-day simple moving average is 0.56, creating a Buy signal.
Fundamental Analysis of Chemomab Therapeutics
Is Chemomab Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Chemomab Therapeutics
Should I short Chemomab Therapeutics stock?
-
CMMB Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Chemomab Therapeutics is a Buy
-
Chemomab Therapeutics Relative Strength Index (RSI) is 37.52, which suggest Chemomab Therapeutics is oversold
-
The Bollinger Bands (25) for Chemomab Therapeutics is (1.26 - 1.38), which suggest Chemomab Therapeutics is a Sell
-
The Bollinger Bands (100) for Chemomab Therapeutics is (1.12 - 1.8), which suggest Chemomab Therapeutics is a Sell
* Chemomab Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.